| Literature DB >> 30894426 |
Carolyn Saylor Hawk1, Carolina Coelho2, Diane Sthefany Lima de Oliveira3, Verenice Paredes4,5, Patrícia Albuquerque6, Anamélia Lorenzetti Bocca3, Ananésia Correa Dos Santos5, Victoria Rusakova7, Heather Holemon7, Ildinete Silva-Pereira3, Maria Sueli Soares Felipe8, Hideo Yagita9, André Moraes Nicola10, Arturo Casadevall11.
Abstract
Abs exert several of their effector functions by binding to cell surface receptors. For murine IgG3 (mIgG3), the identity of its receptors (and the very existence of a receptor) is still under debate, as not all mIgG3 functions can be explained by interaction with FcγRI. This implies the existence of an alternate receptor, whose identity we sought to pinpoint. We found that blockage of integrin β1 selectively hampered binding of mIgG3 to macrophages and mIgG3-mediated phagocytosis. Manganese, an integrin activator, increased mIgG3 binding to macrophages. Blockage of FcγRI or Itgb1 inhibited binding of different mIgG3 Abs to variable extents. Our results are consistent with the notion that Itgb1 functions as part of an IgG receptor complex. Given the more ancient origin of integrins in comparison with FcγR, this observation could have far-ranging implications for our understanding of the evolution of Ab-mediated immunity as well as in immunity to microorganisms, pathogenesis of autoimmune diseases, and Ab engineering.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30894426 PMCID: PMC6759214 DOI: 10.4049/jimmunol.1701795
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422